Global Multiparticulate Drug Delivery System Market Growth 2025-2031

Publication ID:

LPI06259502

Publication Date:

June 11, 2025

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global Multiparticulate Drug Delivery System market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Multiparticulate systems also face some challenges, such as production equipment limitations, long production steps, many influencing factors, and potential healing and stability issues. Take pellet tableting as an example. Due to the difficulty of the pellet tableting process, although the product can improve bioavailability, reduce drug dosage, and alleviate adverse reactions, it is easy to delaminate during the tableting process, and the coating film becomes compressed after being coated. It is easy to break, and the pellets collide and fuse with each other when pressed into tablets, and cannot quickly disintegrate into a single pellet in the gastrointestinal tract after taking it.
The 鈥淢ultiparticulate Drug Delivery System Industry Forecast鈥� looks at past sales and reviews total world Multiparticulate Drug Delivery System sales in 2024, providing a comprehensive analysis by region and market sector of projected Multiparticulate Drug Delivery System sales for 2025 through 2031. With Multiparticulate Drug Delivery System sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Multiparticulate Drug Delivery System industry.
This Insight Report provides a comprehensive analysis of the global Multiparticulate Drug Delivery System landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Multiparticulate Drug Delivery System portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Multiparticulate Drug Delivery System market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Multiparticulate Drug Delivery System and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Multiparticulate Drug Delivery System.
This report presents a comprehensive overview, market shares, and growth opportunities of Multiparticulate Drug Delivery System market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Granules
Micropills
Segmentation by Application:
Hospital
Clinic
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Elan drug Technologies
Rochling Group
Janssen
Pfizer
Novartis
GlaxoSmithKline
Sanofi
Bayer
Key Questions Addressed in this Report
What is the 10-year outlook for the global Multiparticulate Drug Delivery System market?
What factors are driving Multiparticulate Drug Delivery System market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Multiparticulate Drug Delivery System market opportunities vary by end market size?
How does Multiparticulate Drug Delivery System break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Multiparticulate Drug Delivery System Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Multiparticulate Drug Delivery System by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Multiparticulate Drug Delivery System by Country/Region, 2020, 2024 & 2031
2.2 Multiparticulate Drug Delivery System Segment by Type
2.2.1 Granules
2.2.2 Micropills
2.3 Multiparticulate Drug Delivery System Sales by Type
2.3.1 Global Multiparticulate Drug Delivery System Sales Market Share by Type (2020-2025)
2.3.2 Global Multiparticulate Drug Delivery System Revenue and Market Share by Type (2020-2025)
2.3.3 Global Multiparticulate Drug Delivery System Sale Price by Type (2020-2025)
2.4 Multiparticulate Drug Delivery System Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Multiparticulate Drug Delivery System Sales by Application
2.5.1 Global Multiparticulate Drug Delivery System Sale Market Share by Application (2020-2025)
2.5.2 Global Multiparticulate Drug Delivery System Revenue and Market Share by Application (2020-2025)
2.5.3 Global Multiparticulate Drug Delivery System Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Multiparticulate Drug Delivery System Breakdown Data by Company
3.1.1 Global Multiparticulate Drug Delivery System Annual Sales by Company (2020-2025)
3.1.2 Global Multiparticulate Drug Delivery System Sales Market Share by Company (2020-2025)
3.2 Global Multiparticulate Drug Delivery System Annual Revenue by Company (2020-2025)
3.2.1 Global Multiparticulate Drug Delivery System Revenue by Company (2020-2025)
3.2.2 Global Multiparticulate Drug Delivery System Revenue Market Share by Company (2020-2025)
3.3 Global Multiparticulate Drug Delivery System Sale Price by Company
3.4 Key Manufacturers Multiparticulate Drug Delivery System Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Multiparticulate Drug Delivery System Product Location Distribution
3.4.2 Players Multiparticulate Drug Delivery System Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Multiparticulate Drug Delivery System by Geographic Region
4.1 World Historic Multiparticulate Drug Delivery System Market Size by Geographic Region (2020-2025)
4.1.1 Global Multiparticulate Drug Delivery System Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Multiparticulate Drug Delivery System Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Multiparticulate Drug Delivery System Market Size by Country/Region (2020-2025)
4.2.1 Global Multiparticulate Drug Delivery System Annual Sales by Country/Region (2020-2025)
4.2.2 Global Multiparticulate Drug Delivery System Annual Revenue by Country/Region (2020-2025)
4.3 Americas Multiparticulate Drug Delivery System Sales Growth
4.4 APAC Multiparticulate Drug Delivery System Sales Growth
4.5 Europe Multiparticulate Drug Delivery System Sales Growth
4.6 Middle East & Africa Multiparticulate Drug Delivery System Sales Growth
5 Americas
5.1 Americas Multiparticulate Drug Delivery System Sales by Country
5.1.1 Americas Multiparticulate Drug Delivery System Sales by Country (2020-2025)
5.1.2 Americas Multiparticulate Drug Delivery System Revenue by Country (2020-2025)
5.2 Americas Multiparticulate Drug Delivery System Sales by Type (2020-2025)
5.3 Americas Multiparticulate Drug Delivery System Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Multiparticulate Drug Delivery System Sales by Region
6.1.1 APAC Multiparticulate Drug Delivery System Sales by Region (2020-2025)
6.1.2 APAC Multiparticulate Drug Delivery System Revenue by Region (2020-2025)
6.2 APAC Multiparticulate Drug Delivery System Sales by Type (2020-2025)
6.3 APAC Multiparticulate Drug Delivery System Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Multiparticulate Drug Delivery System by Country
7.1.1 Europe Multiparticulate Drug Delivery System Sales by Country (2020-2025)
7.1.2 Europe Multiparticulate Drug Delivery System Revenue by Country (2020-2025)
7.2 Europe Multiparticulate Drug Delivery System Sales by Type (2020-2025)
7.3 Europe Multiparticulate Drug Delivery System Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Multiparticulate Drug Delivery System by Country
8.1.1 Middle East & Africa Multiparticulate Drug Delivery System Sales by Country (2020-2025)
8.1.2 Middle East & Africa Multiparticulate Drug Delivery System Revenue by Country (2020-2025)
8.2 Middle East & Africa Multiparticulate Drug Delivery System Sales by Type (2020-2025)
8.3 Middle East & Africa Multiparticulate Drug Delivery System Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Multiparticulate Drug Delivery System
10.3 Manufacturing Process Analysis of Multiparticulate Drug Delivery System
10.4 Industry Chain Structure of Multiparticulate Drug Delivery System
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Multiparticulate Drug Delivery System Distributors
11.3 Multiparticulate Drug Delivery System Customer
12 World Forecast Review for Multiparticulate Drug Delivery System by Geographic Region
12.1 Global Multiparticulate Drug Delivery System Market Size Forecast by Region
12.1.1 Global Multiparticulate Drug Delivery System Forecast by Region (2026-2031)
12.1.2 Global Multiparticulate Drug Delivery System Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Multiparticulate Drug Delivery System Forecast by Type (2026-2031)
12.7 Global Multiparticulate Drug Delivery System Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Elan drug Technologies
13.1.1 Elan drug Technologies Company Information
13.1.2 Elan drug Technologies Multiparticulate Drug Delivery System Product Portfolios and Specifications
13.1.3 Elan drug Technologies Multiparticulate Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Elan drug Technologies Main Business Overview
13.1.5 Elan drug Technologies Latest Developments
13.2 Rochling Group
13.2.1 Rochling Group Company Information
13.2.2 Rochling Group Multiparticulate Drug Delivery System Product Portfolios and Specifications
13.2.3 Rochling Group Multiparticulate Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Rochling Group Main Business Overview
13.2.5 Rochling Group Latest Developments
13.3 Janssen
13.3.1 Janssen Company Information
13.3.2 Janssen Multiparticulate Drug Delivery System Product Portfolios and Specifications
13.3.3 Janssen Multiparticulate Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Janssen Main Business Overview
13.3.5 Janssen Latest Developments
13.4 Pfizer
13.4.1 Pfizer Company Information
13.4.2 Pfizer Multiparticulate Drug Delivery System Product Portfolios and Specifications
13.4.3 Pfizer Multiparticulate Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Pfizer Main Business Overview
13.4.5 Pfizer Latest Developments
13.5 Novartis
13.5.1 Novartis Company Information
13.5.2 Novartis Multiparticulate Drug Delivery System Product Portfolios and Specifications
13.5.3 Novartis Multiparticulate Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Novartis Main Business Overview
13.5.5 Novartis Latest Developments
13.6 GlaxoSmithKline
13.6.1 GlaxoSmithKline Company Information
13.6.2 GlaxoSmithKline Multiparticulate Drug Delivery System Product Portfolios and Specifications
13.6.3 GlaxoSmithKline Multiparticulate Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 GlaxoSmithKline Main Business Overview
13.6.5 GlaxoSmithKline Latest Developments
13.7 Sanofi
13.7.1 Sanofi Company Information
13.7.2 Sanofi Multiparticulate Drug Delivery System Product Portfolios and Specifications
13.7.3 Sanofi Multiparticulate Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Sanofi Main Business Overview
13.7.5 Sanofi Latest Developments
13.8 Bayer
13.8.1 Bayer Company Information
13.8.2 Bayer Multiparticulate Drug Delivery System Product Portfolios and Specifications
13.8.3 Bayer Multiparticulate Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Bayer Main Business Overview
13.8.5 Bayer Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂